Anna Santacruz

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

Randall J. Bateman, Chengjie Xiong, Tammie L.S. Benzinger et al. · New England Journal of Medicine · 2012 · 3.7K citations · Full text

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease

Stephen Salloway, Martin R. Farlow, Eric McDade et al. · Nature Medicine · 2021 · 349 citations · Full text

Neurodegenerative Diseases, Neurobiology Of Disease, Alzheimer's Disease +9

The DIAN‐TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model

Randall J. Bateman, Tammie L.S. Benzinger, Scott Berry et al. · Alzheimer s & Dementia · 2016 · 287 citations · Full text

Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials

Stacie Weninger, María C. Carrillo, Billy Dunn et al. · Alzheimer s & Dementia · 2016 · 34 citations · Full text

Neurodegenerative Diseases, Preventive Medicine, Alzheimer's Disease +12

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial

Randall J. Bateman, Yan Li, Eric McDade et al. · The Lancet Neurology · 2025 · 26 citations

Neurodegenerative Diseases, Geriatric Neurology, Alzheimer's Disease +12